Hallmarks of neurodegenerative diseases
- PMID: 36803602
- DOI: 10.1016/j.cell.2022.12.032
Hallmarks of neurodegenerative diseases
Abstract
Decades of research have identified genetic factors and biochemical pathways involved in neurodegenerative diseases (NDDs). We present evidence for the following eight hallmarks of NDD: pathological protein aggregation, synaptic and neuronal network dysfunction, aberrant proteostasis, cytoskeletal abnormalities, altered energy homeostasis, DNA and RNA defects, inflammation, and neuronal cell death. We describe the hallmarks, their biomarkers, and their interactions as a framework to study NDDs using a holistic approach. The framework can serve as a basis for defining pathogenic mechanisms, categorizing different NDDs based on their primary hallmarks, stratifying patients within a specific NDD, and designing multi-targeted, personalized therapies to effectively halt NDDs.
Keywords: DNA and RNA defects; cytoskeletal defects; energy homeostasis; hallmarks; inflammation; neurodegeneration; neurodegenerative disease; protein aggregation; proteostasis; synaptic and neuronal network dysfunction.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests D.M.H. is a co-founder with equity in C2N Diagnostics. He consults for C2N Diagnostics, Genentech, Denali, Cajal Neurosciences, and Alector. H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Passage Bio, Pinteon Therapeutics, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). L.V.D.B. is head of the Scientific Advisory Board of Augustine Therapeutics (Leuven, Belgium) and is part of the Investment Advisory Board of Droia Ventures (Meise, Belgium). L.V.D.B. has a patent on the use of HDAC inhibitors to treat CMT disease (Serial No. 61/404,796).
Similar articles
-
Protein aggregation in cell biology: An aggregomics perspective of health and disease.Semin Cell Dev Biol. 2020 Mar;99:40-54. doi: 10.1016/j.semcdb.2018.05.003. Epub 2018 Jun 28. Semin Cell Dev Biol. 2020. PMID: 29753879 Review.
-
Innate immune activation in neurodegenerative diseases.Immunity. 2024 Apr 9;57(4):790-814. doi: 10.1016/j.immuni.2024.03.010. Immunity. 2024. PMID: 38599171 Review.
-
Proteostasis and Proteotoxicity in the Network Medicine Era.Int J Mol Sci. 2020 Sep 3;21(17):6405. doi: 10.3390/ijms21176405. Int J Mol Sci. 2020. PMID: 32899160 Free PMC article. Review.
-
Broken Balance: Emerging Cross-Talk Between Proteostasis and Lipostasis in Neurodegenerative Diseases.Cells. 2025 Jun 4;14(11):845. doi: 10.3390/cells14110845. Cells. 2025. PMID: 40498021 Free PMC article. Review.
-
Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.Biofactors. 2017 Nov;43(6):737-759. doi: 10.1002/biof.1264. Epub 2016 Feb 22. Biofactors. 2017. PMID: 26899445 Review.
Cited by
-
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy.Biomedicines. 2023 Dec 17;11(12):3333. doi: 10.3390/biomedicines11123333. Biomedicines. 2023. PMID: 38137554 Free PMC article. Review.
-
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing.Int J Mol Sci. 2023 Nov 27;24(23):16798. doi: 10.3390/ijms242316798. Int J Mol Sci. 2023. PMID: 38069121 Free PMC article. Review.
-
NRF2 Deficiency Promotes Ferroptosis of Astrocytes Mediated by Oxidative Stress in Alzheimer's Disease.Mol Neurobiol. 2024 Oct;61(10):7517-7533. doi: 10.1007/s12035-024-04023-9. Epub 2024 Feb 24. Mol Neurobiol. 2024. PMID: 38401046
-
Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson's disease patients.Sci Data. 2024 Oct 15;11(1):1128. doi: 10.1038/s41597-024-03909-6. Sci Data. 2024. PMID: 39406833 Free PMC article.
-
Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones.Biomolecules. 2023 Dec 22;14(1):16. doi: 10.3390/biom14010016. Biomolecules. 2023. PMID: 38254616 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical